Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

In a report prepared for the Scottish Health Service Haemophilia Centre/Transfusion Service Directors' meeting, Dr Craske described the supply of Factor 9 to Haemophilia B patients as "always more than adequate".

  • Read more about In a report prepared for the Scottish Health Service Haemophilia Centre/Transfusion Service Directors' meeting, Dr Craske described the supply of Factor 9 to Haemophilia B patients as "always more than adequate".

Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 27,487 units.

  • Read more about Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 27,487 units.

Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 30,752 units.

  • Read more about Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 30,752 units.

Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 29,241 units.

  • Read more about Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 29,241 units.

Dr Craske prepared a report titled Current Situation Regarding AIDS, attaching diagrams based on the reports received from haemophilia centres on the patients who received the same batches of blood products as the Cardiff and Bristol AIDS cases.

  • Read more about Dr Craske prepared a report titled Current Situation Regarding AIDS, attaching diagrams based on the reports received from haemophilia centres on the patients who received the same batches of blood products as the Cardiff and Bristol AIDS cases.

Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 25,005 units.

  • Read more about Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 25,005 units.

Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 21,000 units.

  • Read more about Information received from haemophilia centres' annual returns shows the average amount of NHS Factor 9 used per Haemophilia B patient that year was 21,000 units.

There was an increase of fresh frozen plasma in 1980 both of the overall amount used and the average per patient. The average used per Haemophilia B patient was now 23,301 units.

  • Read more about There was an increase of fresh frozen plasma in 1980 both of the overall amount used and the average per patient. The average used per Haemophilia B patient was now 23,301 units.

In 1978, the average amount used per patient was 21,000 units, which was an increase from 1976, but said to be a decrease from 1977 when the annual figure was 23,000 units

  • Read more about In 1978, the average amount used per patient was 21,000 units, which was an increase from 1976, but said to be a decrease from 1977 when the annual figure was 23,000 units

By 1976 Factor 9 concentrate was the dominant treatment with comparatively little use of fresh frozen plasma. The 1976 annual returns recorded that 396 patients were treated with a total of 5,561,834 Factor 9 units in the UK. The average per patient was 18,790 units. 60 patients were on home treatment.

  • Read more about By 1976 Factor 9 concentrate was the dominant treatment with comparatively little use of fresh frozen plasma. The 1976 annual returns recorded that 396 patients were treated with a total of 5,561,834 Factor 9 units in the UK. The average per patient was 18,790 units. 60 patients were on home treatment.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.